Sanofi Genzyme

Associate Director Global Scientific Communications – Rare Blood Disorders

Posted on: 14 Apr 2021

Cambridge, MA

Job Description

Position Overview:

This position is a vital member of the Global Medical Affairs team who will oversee the development and execution of scientific communications strategies and plans in Rare Blood Disorders, world-wide. This highly visible role will engage key thought leaders in Rare Blood Disorders, while collaborating cross-functionally with Project teams, Regions, Clinical Development, and the broader Medical Affairs team, in the oversight of medical activities for a launch product for Sanofi Rare Blood Disorders., The Associate Director, Scientific Communications manages the development of the communications strategy and clinically focused communications including core slide decks, evidence-based scientific platform, disease awareness videos  as well as supporting medical affairs advisory board’s strategy and content.  Involvement with publication’s development may include publication plan development, reviewing manuscript drafts and collaborating with the appropriate leads on strategy for data dissemination.

Roles and Responsibilities:

Become a subject matter expert and internal liaison for Rare Blood Disorders.

Lead and manage the execution of the global medical communication and publication plan strategies for Rare Blood Disorders, including presence at scientific congresses, with an understanding of how these activities support the overall Medical Affairs and brand strategy.

Lead and manage the development and execution of key global medical education programs to fill learning gaps that are identified through the medical affairs annual plan. Tactics may include live meetings (ie, satellite symposia) or online programs.

Generate Annual Medical Communications and Publications plans in conjunction with the Project teams based on scientific and unmet medical needs.

Understand and follow the various compliance policies in place for global and US publications and medical education activities.

Continuously surveying the medical and scientific literature for the identification of relevant publications.  Leading development of monthly literature updates and annotated summaries of key articles.

Managing external vendors/medical agencies assisting with medical content planning and execution and managing budgets.

Supporting development of medical/scientific content for scientific exchange, advisory boards and training.

Ensuring delivery of high-quality, fair-balanced, scientifically/clinically accurate medical communications deliverables in accordance with established timelines, compliance guidelines/policies, and budgets.

Leading the creation of annual and long-range global medical communications plans and budgets.

Overseeing internal and external medical communication related to congress activities.

Basic Qualifications:

Doctoral level degree (Ph.D., Pharm.D., or M.D.) in life sciences with minimum of 5 years bio-pharmaceutical industry experience within Medical or Clinical Affairs.

Excellent written and verbal communication skills, with the ability to understand and effectively communicate complex scientific and clinical data to internal and external stakeholders.

Preferred Qualifications:

Experience in Medical Communications and/or Publications Management.

Clinical knowledge in Rare Blood Disorders.

Ability to collaborate and build solid working relationships cross-functionally.

Ability to manage multiple projects simultaneously, thinks critically, and adheres to deadlines.

Demonstrated functional knowledge of applicable guidelines including ICMJE, ACCME, OIG, PhRMA, GPP & GCP.

Result- and customer-focused.

Highly committed and flexible working attitude.

Ability to understand, critically analyze, and summarize complex scientific and medical data and understand risk taking approach with regards to claims.

Critical thinking – ability to challenge the status quo.

Experience working in a complex organization and the ability to operate in a matrix, team-oriented structure.

Demonstrate track record in building and maintaining a network of internal and external experts, experience in working across and building effective partnerships.

Experience in supervising and managing medical writing tasks and tools, including electronic tools, including subcontracting medical writing tasks.

Sanofi Genzyme

Cambridge, MA

As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.

Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.

Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.

Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.